摘要
目的探析NT-proBNP下降率对心衰疗效和再住院率的评估价值。方法选取200例心衰患者,依据NT-proBNP下降率将其分为两组,研究组NT-proBNP下降率在30%以上,对照组NT-proBNP下降率在30%以下,对比分析两组临床疗效、再住院率和死亡情况。结果研究组治疗效果良好率为87.50%,对照组为71.25%,P<0.05,差异具有统计学意义;对两组患者随访半年,研究组再住院率为6.67%,对照组为21.25%,P<0.05,差异具有统计学意义;研究组死亡几率1.67%,对照组为12.5%,P<0.05,差异具有统计学意义。结论血清NT-proBNP下降率评估心衰患者的疗效及再住院率价值较高,且对判断患者预后情况具有重要的意义。
Objective NT-proBNP decreased rate of heart failure efifcacy and assess the value of re-hospitalization rates. MethodsSelected 200 cases of patients with heart failure, NT-proBNP in accordance with the rate of decline will be divided into two groups of clinical efifcacy study group NT-proBNP decreased rate of 30% in the control group rate of decrease in NT-proBNP below 30%, comparative analysis , readmission rates and mortality. ResultsStudy group treatment effect good chance of 87.50% in the control group was 71.25%,P〈0.05, had difference statistically significance. two groups of patients were followed up for six months, the study group readmission rate was 6.67%, the control group was 21.25%,P〈0.05, had difference statistically significance. 1.67% chance of death study group, 12.5% in the control group,P〈0.05, had difference statistically signiifcance. Conclusion The serum NT-proBNP decreased rate of heart failure patients to assess the efficacy and readmission rates higher value, and has great signiifcance in judging the prognosis of patients.
出处
《中国继续医学教育》
2015年第29期40-41,共2页
China Continuing Medical Education
